Delivery Order SPE2DB20D1100-SPE2DB24FA9D0
- Not listed
- This federal contract award, valued at $1,032.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Atovaquone-Proguanil 250-100 UD 24S. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $21,722.79, is a firm fixed price delivery order for ATOVAQUONE-PROGUANIL 250-100 100S, a specialty pharmaceutical product. The award has no set-aside designation and is part of a larger indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,501.96 firm fixed-price delivery order is for the provision of 4,564,427,007 units of the medication Atovaquone-Proguanil 250-100. The contract has an ultimate completion date of April 30, 2024 and was awarded on April 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,594.70 firm-fixed-price delivery order is for the supply of 4,565,860,237 units of the pharmaceutical product Atovaquone-Proguanil 250-100 in 100-count bottles. The award has a completion date of September 19, 2024 and is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, holds...
- This federal contract award is for a delivery order placed with Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical to supply 4,563,799,752 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The firm fixed price contract has a potential value of $4,994.03 and a completion date of February 29, 2024. This delivery order is part of a...
- This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 UD 24S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order worth $4,224.13, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $70,386.43. The contract was awarded by the Defense Logistics Agency (DLA) to supply Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,270.19 Firm Fixed Price Delivery Order is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $11,233.75 for the supply of 4564616272 ! ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the Department of Defense (DoD) responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces. Amerisourcebergen, a large pharmaceutical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA9D0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $17,737.50, is a firm fixed price delivery order for the supply of 4,564,071,288 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC was awarded solely to Amerisourcebergen Drug Corp and does not fall under any overarching contract vehicles. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 3/25/24 |